ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 939 filers reported holding ASTRAZENECA PLC in Q4 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $34,876 | -5.4% | 515 | 0.0% | 0.02% | 0.0% |
Q2 2023 | $36,859 | +3.1% | 515 | 0.0% | 0.02% | -6.2% |
Q1 2023 | $35,746 | +102031.4% | 515 | 0.0% | 0.02% | 0.0% |
Q4 2022 | $35 | -99.9% | 515 | 0.0% | 0.02% | +14.3% |
Q3 2022 | $28,000 | -36.4% | 515 | -22.0% | 0.01% | -30.0% |
Q2 2022 | $44,000 | 0.0% | 660 | 0.0% | 0.02% | +17.6% |
Q1 2022 | $44,000 | +15.8% | 660 | 0.0% | 0.02% | +6.2% |
Q4 2021 | $38,000 | -5.0% | 660 | 0.0% | 0.02% | -5.9% |
Q3 2021 | $40,000 | 0.0% | 660 | 0.0% | 0.02% | -5.6% |
Q2 2021 | $40,000 | +60.0% | 660 | +33.3% | 0.02% | +50.0% |
Q1 2021 | $25,000 | 0.0% | 495 | 0.0% | 0.01% | -7.7% |
Q4 2020 | $25,000 | -7.4% | 495 | 0.0% | 0.01% | -13.3% |
Q3 2020 | $27,000 | +3.8% | 495 | 0.0% | 0.02% | -11.8% |
Q2 2020 | $26,000 | +18.2% | 495 | 0.0% | 0.02% | 0.0% |
Q1 2020 | $22,000 | -12.0% | 495 | 0.0% | 0.02% | +6.2% |
Q4 2019 | $25,000 | +13.6% | 495 | 0.0% | 0.02% | 0.0% |
Q3 2019 | $22,000 | – | 495 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |